Increase/Decrease in Cash: The total change in cash for the company over the given period.
Alzamend Neuro, Inc. (ALZN) had Increase/Decrease in Cash of $-8.92M for the most recently reported fiscal year, ending 2023-04-30.
| Income Statement Financials | |
-- |
|
$-14.88M |
|
-- |
|
-- |
|
$14.87M |
|
$-14.87M |
|
$-0.01M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-14.87M |
|
$-14.85M |
|
6.50M |
|
6.50M |
|
$-2.25 |
|
$-2.25 |
|
| Balance Sheet Financials | |
$5.84M |
|
$0.08M |
|
$0.08M |
|
$5.92M |
|
$2.87M |
|
-- |
|
-- |
|
$2.87M |
|
$3.05M |
|
$3.05M |
|
$3.05M |
|
6.47M |
|
| Cash Flow Statement Financials | |
$-8.92M |
|
-- |
|
$0.00M |
|
$14.06M |
|
$5.14M |
|
|
Increase/Decrease in Cash |
$-8.92M |
$3.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-488.53% |
|
-488.53% |
|
-251.51% |
|
-488.53% |
|
$0.47 |
|
$-1.37 |
|
$-1.37 |
|